Navigation Links
CYIG Awarded China's "Top 100 Enterprises" in New Pharmaceuticals, Selected as National "'Torch Plan' Key High-Tech Enterprise"
Date:12/10/2007

NEW YORK, Dec. 10 /Xinhua-PRNewswire-FirstCall/ -- China YCT International Group, Inc. (OTC Bulletin Board: CYIG; hereinafter the "Company") announced today that Shandong Yongchuntang Biology Technology Co. Ltd. ("Shandong YCT"), the Company's wholly-owned operating subsidiary in Shandong Province, China, has been awarded the honor of China's "Top 100 Enterprises" in the bioengineering and new pharmaceuticals sector. The award was conferred by the Small- and Medium-sized Enterprises Research Center (SMERC) of the State Development and Planning Commission (SDPC), the country's premier research institution and think tank on small- and medium-sized enterprises. The rigorous selection process for the nation's "Top 100 Enterprises by Industry" began a year ago, with final winners for over 50 industrial sectors chosen from over 10,000 enterprises nationwide. Major indicators used in the selection included sales revenue in the most recent three years, production scale and capacity, actual output, and tax contribution.

The Company also announced on the same day that Shandong Yongchuntang Biology Technology Co. Ltd. has been selected as a National "Torch Plan" Key High-Tech Enterprise. Established in 1989 and administered through the Ministry of Science and Technology, the "Torch Plan" is China's premier central government-sponsored high-tech promotion program with a mandate to promote the industrialization, commercialization and internationalization of advanced technologies throughout the country. Shandong Yongchuntang Biology Technology Co. Ltd. is the first high-tech enterprise from Sishui County to be included in the plan.

"Our selection as a leading enterprise in the highly competitive bioengineering and new pharmaceuticals field, as well as our inclusion in the National 'Torch Plan', once again attest to the strengths and capabilities of our company. These two honors represent an important milestone in our persistent pursuit of developing the highest-quality ginkgo-based health and pharmaceutical products for the benefit of the human race," said Mr. Yan Tinghe, Chairman & CEO of CYIG and Shandong YCT.

China YCT International Group, Inc., through its operating subsidiary, Shandong Yongchuntang Biology Technology Co. Ltd. ("Shandong YCT"), a corporation organized under the laws of the People's Republic of China, is engaged in the business of the distribution of gingko-based health and beauty products. All of Shandong YCT's business is currently in China.

This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks described in statements filed from time to time with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the Company, are expressly qualified by the cautionary statements that may accompany the forward-looking statements. In addition, the Company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.

For more information, please contact:

Peter D. Zhou

Tel: +1-212-232-0120


'/>"/>
SOURCE China YCT International Group, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. GeneNews CSO Dr. CC Liew awarded state honour by the Government of Malaysia
2. Mirus Bio Awarded Grants & Contracts of Over $5 Million
3. ICx Awarded $1.5 M Contract by Department of Homeland Security for Development of Next Generation Bio Aerosol Systems
4. ViPS Awarded Enterprise Systems Development (ESD) Contract By CMS
5. GlaxoSmithKline Awarded U.S. Department of Defense Contract to Pursue Novel Antibacterial Research Program
6. Isis Announces $4.2 Million in Government Contracts Awarded to Its Ibis Subsidiary for Biodefense Applications Development
7. Foundation for Biomedical Research Board Chairman Awarded Congressional Gold Medal
8. Isis Awarded $1.5 Million NIH Grant to Improve Chemical Properties of RNAi-Based Therapeutics
9. Caliper Life Sciences Awarded National Institute of Environmental Health Services Contract Valued to $7.0 Million
10. Implicit Awarded US $16.3 Million U.S. Government Contract to Develop Immunomodulatory Drug for Biodefense Threats
11. BIO-key(R) Awarded Contract to Deploy Incident Reporting System for Littleton, CO Police Department
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... BioMedGPS announces ... addition of its newest module, US Hemostats & Sealants. , SmartTRAK’s US Market ... hemostats, fibrin sealants, synthetic sealants and biologic sealants used in surgical applications. BioMedGPS ...
(Date:10/11/2017)... ... October 11, 2017 , ... The CRISPR-Cas9 system ... experiments and avoiding the use of exogenous expression plasmids. The simplicity of programming ... systematic gain-of-function studies. , This complement to loss-of-function studies, such as with ...
(Date:10/11/2017)... a leading provider of patient support solutions, has announced the ... which will launch this week. The VMS CNEs will address ... enhance the patient care experience by delivering peer-to-peer education programs ... to help women who have been diagnosed and are being ... ...
(Date:10/11/2017)... ... October 11, 2017 , ... Singh Biotechnology today announced ... to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator of Transcription 3) B ... to cross the cell membrane and bind intracellular STAT3 and inhibit its function. ...
Breaking Biology Technology:
(Date:4/11/2017)... 11, 2017 Research and Markets has announced ... report to their offering. ... global eye tracking market to grow at a CAGR of 30.37% ... Tracking Market 2017-2021, has been prepared based on an in-depth market ... landscape and its growth prospects over the coming years. The report ...
(Date:4/5/2017)... 5, 2017  The Allen Institute for Cell Science ... a one-of-a-kind portal and dynamic digital window into the ... the first application of deep learning to create predictive ... lines and a growing suite of powerful tools. The ... and future publicly available resources created and shared by ...
(Date:4/3/2017)... , April 3, 2017  Data ... precision engineering platform, detected a statistically significant ... product prior to treatment and objective response ... the potential to predict whether cancer patients ... to treatment, as well as to improve ...
Breaking Biology News(10 mins):